These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

360 related articles for article (PubMed ID: 22074752)

  • 1. Potential psychosocial risk factors for chronic TMD: descriptive data and empirically identified domains from the OPPERA case-control study.
    Fillingim RB; Ohrbach R; Greenspan JD; Knott C; Dubner R; Bair E; Baraian C; Slade GD; Maixner W
    J Pain; 2011 Nov; 12(11 Suppl):T46-60. PubMed ID: 22074752
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Psychological factors associated with development of TMD: the OPPERA prospective cohort study.
    Fillingim RB; Ohrbach R; Greenspan JD; Knott C; Diatchenko L; Dubner R; Bair E; Baraian C; Mack N; Slade GD; Maixner W
    J Pain; 2013 Dec; 14(12 Suppl):T75-90. PubMed ID: 24275225
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potential autonomic risk factors for chronic TMD: descriptive data and empirically identified domains from the OPPERA case-control study.
    Maixner W; Greenspan JD; Dubner R; Bair E; Mulkey F; Miller V; Knott C; Slade GD; Ohrbach R; Diatchenko L; Fillingim RB
    J Pain; 2011 Nov; 12(11 Suppl):T75-91. PubMed ID: 22074754
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical findings and pain symptoms as potential risk factors for chronic TMD: descriptive data and empirically identified domains from the OPPERA case-control study.
    Ohrbach R; Fillingim RB; Mulkey F; Gonzalez Y; Gordon S; Gremillion H; Lim PF; Ribeiro-Dasilva M; Greenspan JD; Knott C; Maixner W; Slade G
    J Pain; 2011 Nov; 12(11 Suppl):T27-45. PubMed ID: 22074750
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pain sensitivity risk factors for chronic TMD: descriptive data and empirically identified domains from the OPPERA case control study.
    Greenspan JD; Slade GD; Bair E; Dubner R; Fillingim RB; Ohrbach R; Knott C; Mulkey F; Rothwell R; Maixner W
    J Pain; 2011 Nov; 12(11 Suppl):T61-74. PubMed ID: 22074753
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potential genetic risk factors for chronic TMD: genetic associations from the OPPERA case control study.
    Smith SB; Maixner DW; Greenspan JD; Dubner R; Fillingim RB; Ohrbach R; Knott C; Slade GD; Bair E; Gibson DG; Zaykin DV; Weir BS; Maixner W; Diatchenko L
    J Pain; 2011 Nov; 12(11 Suppl):T92-101. PubMed ID: 22074755
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Study methods, recruitment, sociodemographic findings, and demographic representativeness in the OPPERA study.
    Slade GD; Bair E; By K; Mulkey F; Baraian C; Rothwell R; Reynolds M; Miller V; Gonzalez Y; Gordon S; Ribeiro-Dasilva M; Lim PF; Greenspan JD; Dubner R; Fillingim RB; Diatchenko L; Maixner W; Dampier D; Knott C; Ohrbach R
    J Pain; 2011 Nov; 12(11 Suppl):T12-26. PubMed ID: 22074749
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multivariable modeling of phenotypic risk factors for first-onset TMD: the OPPERA prospective cohort study.
    Bair E; Ohrbach R; Fillingim RB; Greenspan JD; Dubner R; Diatchenko L; Helgeson E; Knott C; Maixner W; Slade GD
    J Pain; 2013 Dec; 14(12 Suppl):T102-15. PubMed ID: 24275218
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pain sensitivity and autonomic factors associated with development of TMD: the OPPERA prospective cohort study.
    Greenspan JD; Slade GD; Bair E; Dubner R; Fillingim RB; Ohrbach R; Knott C; Diatchenko L; Liu Q; Maixner W
    J Pain; 2013 Dec; 14(12 Suppl):T63-74.e1-6. PubMed ID: 24275224
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical orofacial characteristics associated with risk of first-onset TMD: the OPPERA prospective cohort study.
    Ohrbach R; Bair E; Fillingim RB; Gonzalez Y; Gordon SM; Lim PF; Ribeiro-Dasilva M; Diatchenko L; Dubner R; Greenspan JD; Knott C; Maixner W; Smith SB; Slade GD
    J Pain; 2013 Dec; 14(12 Suppl):T33-50. PubMed ID: 24275222
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Painful Temporomandibular Disorder: Decade of Discovery from OPPERA Studies.
    Slade GD; Ohrbach R; Greenspan JD; Fillingim RB; Bair E; Sanders AE; Dubner R; Diatchenko L; Meloto CB; Smith S; Maixner W
    J Dent Res; 2016 Sep; 95(10):1084-92. PubMed ID: 27339423
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Temporal change in headache and its contribution to the risk of developing first-onset temporomandibular disorder in the Orofacial Pain: Prospective Evaluation and Risk Assessment (OPPERA) study.
    Tchivileva IE; Ohrbach R; Fillingim RB; Greenspan JD; Maixner W; Slade GD
    Pain; 2017 Jan; 158(1):120-129. PubMed ID: 27984525
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Summary of findings from the OPPERA prospective cohort study of incidence of first-onset temporomandibular disorder: implications and future directions.
    Slade GD; Fillingim RB; Sanders AE; Bair E; Greenspan JD; Ohrbach R; Dubner R; Diatchenko L; Smith SB; Knott C; Maixner W
    J Pain; 2013 Dec; 14(12 Suppl):T116-24. PubMed ID: 24275219
    [TBL] [Abstract][Full Text] [Related]  

  • 14. General health status and incidence of first-onset temporomandibular disorder: the OPPERA prospective cohort study.
    Sanders AE; Slade GD; Bair E; Fillingim RB; Knott C; Dubner R; Greenspan JD; Maixner W; Ohrbach R
    J Pain; 2013 Dec; 14(12 Suppl):T51-62. PubMed ID: 24275223
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distribution of depression, somatization and pain-related impairment in patients with chronic temporomandibular disorders.
    Canales GT; Guarda-Nardini L; Rizzatti-Barbosa CM; Conti PCR; Manfredini D
    J Appl Oral Sci; 2019 Jan; 27():e20180210. PubMed ID: 30624469
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term changes in biopsychosocial characteristics related to temporomandibular disorder: findings from the OPPERA study.
    Fillingim RB; Slade GD; Greenspan JD; Dubner R; Maixner W; Bair E; Ohrbach R
    Pain; 2018 Nov; 159(11):2403-2413. PubMed ID: 30028791
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preclinical episodes of orofacial pain symptoms and their association with health care behaviors in the OPPERA prospective cohort study.
    Slade GD; Sanders AE; Bair E; Brownstein N; Dampier D; Knott C; Fillingim R; Maixner WO; Smith S; Greenspan J; Dubner R; Ohrbach R
    Pain; 2013 May; 154(5):750-760. PubMed ID: 23531476
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic variants associated with development of TMD and its intermediate phenotypes: the genetic architecture of TMD in the OPPERA prospective cohort study.
    Smith SB; Mir E; Bair E; Slade GD; Dubner R; Fillingim RB; Greenspan JD; Ohrbach R; Knott C; Weir B; Maixner W; Diatchenko L
    J Pain; 2013 Dec; 14(12 Suppl):T91-101.e1-3. PubMed ID: 24275226
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Subjective Sleep Quality Deteriorates Before Development of Painful Temporomandibular Disorder.
    Sanders AE; Akinkugbe AA; Bair E; Fillingim RB; Greenspan JD; Ohrbach R; Dubner R; Maixner W; Slade GD
    J Pain; 2016 Jun; 17(6):669-77. PubMed ID: 26902644
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Causal Mediation in the Development of Painful Temporomandibular Disorder.
    Sanders AE; Akinkugbe AA; Fillingim RB; Ohrbach R; Greenspan JD; Maixner W; Bair E; Slade GD
    J Pain; 2017 Apr; 18(4):428-436. PubMed ID: 27993559
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.